Havas Lynx has shaken up the leadership of its New York team, expanding Claire Knapp’s role to cover the office and hiring ...
The FDA has approved Otsuka Pharmaceutical’s once-daily extended-release capsule Simtriyo (centanafadine) f | Approval of the ...
Some five months after announcing the planned retirement of its longtime CEO Doug Ingram over what the helmsman dubbed an ...
Even as trial setbacks and pipeline adjustment rear their heads, AstraZeneca feels confident that its core business is on ...
In a sudden leadership shift, Legend Biotech announced that its CEO Ying Huang, Ph.D., resigned on Friday, with no permanent ...
Roche’s cancer treatment Avastin (bevacizumab) has long been employed as an off-label option for wet age-related macular ...
One panelist who voted ‘yes,’ Gabriel Alizaidy, M.D., of Maximus Health, argued that there was a “mismatch in real-world data ...
Three years after gaining three liver disease assets in its $952 million buyout of Albireo, Ipsen is struggling to develop ...
Generic drugmakers will face import tariffs in the U.S., President Donald Trump announced this week. Samsung Biologics is ...
With all eyes on Tavneos’ seemingly precarious approval status in the U.S., Amgen is advancing plans to defend the ...
Johnson & Johnson has unveiled massive phase 3 survival data for its dual bispecific combination in earlier-line multiple myeloma, delivering another catalyst that could add a new twist in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results